PRCISR™ CRISPR
Vivlion’s CRISPR-enabled Discovery Platform
Revolutionize your R&D pipeline with our CRISPR solutions
We provide innovative reagents and services to accelerate your CRISPR-driven R&D initiatives. Available in both single and combinatorial formats, our PRCISR™ CRISPR sgRNA libraries are uniformly distributed and designed for high on-target and low off-target activity. Choose from a selection of genome-wide and protein family-focused libraries or customize a library to meet your specific research needs. For those conducting in-house screening experiments, our libraries are delivered as plasmids suitable for lentiviral packaging, together with all necessary protocols for handling the library.
Prefer to outsource your screening projects? Benefit from our bioinformatical expertise in experimental planning and analysis of your CRISPR screening experiment. Our fully integrated CRISPR discovery platform covers every step of the process. Let us handle the details, ensuring a seamless and efficient workflow.
Link to our proprietary PRCISRTM technology
Explore the benefits of working with Vivlion®
Optimal strategy implementation: Our dedicated team provides comprehensive support in planning your CRISPR experiments. |
Uniformity and completeness: Our uniformly distributed PRCISRTM CRISPR libraries ensure that all your target genes are properly represented. |
Dual-targeting enhances performance: PRCISRTM CRISPR libraries achieve > 90% gene editing efficiency. |
Downscale your experiment: PRCISRTM CRISPR libraries allow working with limited cell material (e.g. iPS cells, primary) and deliver reliable results at low coverage. |
Multigenic exploration: Combinatorial PRCISRTM solutions enable genetic interaction mapping and expand the search space for target discovery. |
Tailored services: We deliver tailored screening and bioinformatic services, from experimental planning to sophisticated tools for data analysis and integration. |
Link to our proprietary PRCISRTM technology
“We are thrilled to work with Vivlion for their high-quality CRISPR libraries that have excellent guide representation. The superb quality of their products and technical support has made them a highly valued contributor. Vivlion’s genome-wide CRISPR libraries will enable us to continue discovering synthetic lethal drug targets with lower false negative rates, which will ultimately benefit cancer patients in need of new therapeutic options.”
Contact us
We would like to hear more about your CRISPR questions and applications – please reach out to us by completing the following form: